busulfan has been researched along with Benign Cerebellar Neoplasms in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the study is to evaluate the outcome of young children with high risk localized medulloblastomas (newly diagnosed classical or incompletely resected) treated by high-dose busulfan-thiotepa with autologous stem cell rescue (ASCT) followed by focal radiation therapy (RT)." | 7.80 | High-dose busulfan-thiotepa with autologous stem cell transplantation followed by posterior fossa irradiation in young children with classical or incompletely resected medulloblastoma. ( Bergthold, G; Dhermain, F; Dufour, C; El Kababri, M; Goma, G; Grill, J; Kieffer, V; Raquin, MA; Sainte-Rose, C; Valteau-Couanet, D; Varlet, P, 2014) |
| "The aim of this in-vitro study was to evaluate the combination of busulfan with radiotherapy on TE-671 human medulloblastoma cells since unexpected clinical toxicity of busulfan was reported during the treatment of brain tumors, suggesting a possible radiopotentiation." | 7.68 | In vitro combination of high dose busulfan with radiotherapy on medulloblastoma cells: additive effect without potentiation. ( Bey, P; Chastagner, P; Marchal, C; Merlin, JL; Weber, B, 1991) |
| "The aim of the study is to evaluate the outcome of young children with high risk localized medulloblastomas (newly diagnosed classical or incompletely resected) treated by high-dose busulfan-thiotepa with autologous stem cell rescue (ASCT) followed by focal radiation therapy (RT)." | 3.80 | High-dose busulfan-thiotepa with autologous stem cell transplantation followed by posterior fossa irradiation in young children with classical or incompletely resected medulloblastoma. ( Bergthold, G; Dhermain, F; Dufour, C; El Kababri, M; Goma, G; Grill, J; Kieffer, V; Raquin, MA; Sainte-Rose, C; Valteau-Couanet, D; Varlet, P, 2014) |
| "The aim of this in-vitro study was to evaluate the combination of busulfan with radiotherapy on TE-671 human medulloblastoma cells since unexpected clinical toxicity of busulfan was reported during the treatment of brain tumors, suggesting a possible radiopotentiation." | 3.68 | In vitro combination of high dose busulfan with radiotherapy on medulloblastoma cells: additive effect without potentiation. ( Bey, P; Chastagner, P; Marchal, C; Merlin, JL; Weber, B, 1991) |
| "Primitive neuroectodermal tumors (PNET) originating within the spinal cord are extraordinarily rare." | 1.37 | Intramedullary PNET of the spine: long-term survival after combined modality therapy and subsequent relapse. ( Anson, J; Gollard, RP; Khoury, J; Mason, J; Rosen, L, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergthold, G | 1 |
| El Kababri, M | 1 |
| Varlet, P | 1 |
| Dhermain, F | 1 |
| Sainte-Rose, C | 2 |
| Raquin, MA | 2 |
| Kieffer, V | 1 |
| Goma, G | 1 |
| Grill, J | 2 |
| Valteau-Couanet, D | 2 |
| Dufour, C | 1 |
| Nishikawa, T | 1 |
| Okamoto, Y | 1 |
| Tanabe, T | 1 |
| Shinkoda, Y | 1 |
| Kodama, Y | 1 |
| Higashi, M | 1 |
| Hirano, H | 1 |
| Arita, K | 1 |
| Kawano, Y | 1 |
| Gollard, RP | 1 |
| Rosen, L | 1 |
| Anson, J | 1 |
| Mason, J | 1 |
| Khoury, J | 1 |
| Pérez-Martínez, A | 1 |
| Lassaletta, A | 1 |
| González-Vicent, M | 1 |
| Sevilla, J | 1 |
| Díaz, MA | 1 |
| Madero, L | 1 |
| Ridola, V | 1 |
| Doz, F | 2 |
| Gentet, JC | 1 |
| Frappaz, D | 1 |
| Habrand, JL | 1 |
| Kalifa, C | 2 |
| Dupuis-Girod, S | 1 |
| Hartmann, O | 1 |
| Benhamou, E | 1 |
| Mechinaud, F | 1 |
| Bouffet, E | 1 |
| Coze, C | 1 |
| Foa, C | 1 |
| Magné, N | 1 |
| Bondiau, PY | 1 |
| Otto, J | 1 |
| Thyss, A | 1 |
| Merlin, JL | 1 |
| Chastagner, P | 1 |
| Marchal, C | 1 |
| Weber, B | 1 |
| Bey, P | 1 |
1 review available for busulfan and Benign Cerebellar Neoplasms
| Article | Year |
|---|---|
[High-dose chemotherapy in relapse of medulloblastoma in young children].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cerebellar Ne | 1997 |
1 trial available for busulfan and Benign Cerebellar Neoplasms
| Article | Year |
|---|---|
High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cerebel | 2005 |
6 other studies available for busulfan and Benign Cerebellar Neoplasms
| Article | Year |
|---|---|
High-dose busulfan-thiotepa with autologous stem cell transplantation followed by posterior fossa irradiation in young children with classical or incompletely resected medulloblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cerebellar Neoplasms; Child, Preschool; Co | 2014 |
Unexpectedly high AUC levels in a child who received intravenous busulfan before stem cell transplantation.
Topics: Area Under Curve; Busulfan; Cerebellar Neoplasms; Child; Drug Monitoring; Fatal Outcome; Glutathione | 2010 |
Intramedullary PNET of the spine: long-term survival after combined modality therapy and subsequent relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cerebellar Neoplasms; Chemotherapy, Adjuva | 2011 |
High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Busulfan; Cerebellar Neoplasms; Child | 2007 |
High-dose chemotherapy with autologous stem cell support in an adult with bone marrow relapse of medulloblastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Busulfan; Carboplatin; | 2000 |
In vitro combination of high dose busulfan with radiotherapy on medulloblastoma cells: additive effect without potentiation.
Topics: Busulfan; Cell Line; Cerebellar Neoplasms; Colony-Forming Units Assay; Combined Modality Therapy; Hu | 1991 |